Myoderm, a global leader in clinical trial supply, is pleased to announce the addition of Chief Operating Officer James Lovett. James will work alongside long-time Managing Director Michael Cohen to lead the company on a continued path of growth and global expansion.
“Myoderm is at a very exciting time of growth and opportunity, and I am thrilled to have James as part of the Myoderm team. We are seizing the opportunities to find new and better ways to serve our clients in our evolving industry. I believe James has the vision and expertise to help us do that in the best way for both the company and our clients,” Michael Cohen remarks.
A graduate of Northwestern University and Harvard Law School, James brings decades of leadership experience at global companies such as Covance Inc. and FMC Corporation. During his 14 years at Covance, he led three global business units, for which he developed and implemented strategies to drive growth, foster optimal business partnerships, and build highly-engaged, winning teams.
James also has played leadership roles in industry groups such as Association of Clinical Research Organizations and National Association for Biomedical Research. In the non-profit space, he serves on the Board of the Wistar Institute.
James comments, “With a new warehouse in the UK, an expanded presence in Asia, and an increasing number of clinical trials being served around the world, Myoderm is accelerating growth in its scale and ability to serve our many and diverse clients. I am honored and energized to join the Myoderm leadership team to help build differentiated capabilities while continuing to improve the outstanding service that our clients so strongly value.”
Myoderm is a specialist in global clinical trial supply, with deep expertise in sourcing, management, and labeling of commercial drugs and supplies. Their ingenuity, strategic thinking, and obsession with providing the most efficient, effective, and seamless supply solutions is why top pharmaceutical companies, biotech companies, CROs, and clinical trial packagers around the world rely on Myoderm.